On February 22, 2024, the Minnesota state legislature introduced House Bill (HF) 4206, aiming to curb the acquisition of and control over certain healthcare providers by private equity companies and real estate investment...more
On May 3, 2023, New York State enacted legislation that will require physician practice management services organizations (MSOs) and physician practices to submit a comprehensive filing to the New York State Department of...more
During this session, Partner David Ivill moderated a panel featuring investment bankers at leading financial institutions that discussed the big economic themes they predict for the year ahead, particularly as they impact...more
Join us in person on Miami Beach for exclusive networking and to hear from leading investors helping shape the future of healthcare private equity.
The annual HPE Miami event features a world-class faculty, offers creative...more
2/18/2022
/ Banking Sector ,
Capital Markets ,
Digital Health ,
Distressed Debt ,
Due Diligence ,
Events ,
Financing ,
Fundraisers ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Medical Devices ,
Mental Health ,
Partnerships ,
Pharmaceutical Industry ,
Physicians ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Urgent Care Facilities ,
Value-Based Care
McDermott Will & Emery is delighted to welcome you to a panel discussion on “Private Equity in Healthcare” and a social reception held in conjunction with the SuperReturn International Conference 2020.
Our speakers will...more
2/11/2020
/ Events ,
Foreign Investment ,
Health Care Providers ,
Hospitals ,
Investment Funds ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Physicians ,
Private Equity
In August 27, 2015, the U.S. Department of Health and Human Services (HHS) released the long-awaited and much-anticipated proposed 340B Drug Pricing Program (340B Program) Omnibus Guidance (Proposed Guidance). The Proposed...more
9/1/2015
/ Comment Period ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Draft Guidance ,
Drug Pricing ,
DSH Adjustments ,
GPOs ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Hospitals ,
MCOs ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Recordkeeping Requirements ,
Recovery Audit Contractors (RACs) ,
Section 340B